Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jett, JR
   Spiral computed tomography screening fur lung cancer is ready for prime time
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   J.R. Jett, "Spiral computed tomography screening fur lung cancer is ready for prime time", AM J R CRIT, 163(4), 2001, pp. 812-813
2. Thomas, CF; Tazelaar, HD; Jett, JR
   Typical and atypical pulmonary carcinoids - outcome in patients presentingwith regional lymph node involvement
   CHEST
   
   C.F. Thomas et al., "Typical and atypical pulmonary carcinoids - outcome in patients presentingwith regional lymph node involvement", CHEST, 119(4), 2001, pp. 1143-1150
3. Nicholson, SA; Okby, NT; Khan, MA; Welsh, JA; McMenamin, MG; Travis, WD; Jett, JR; Tazelaar, HD; Trastek, V; Pairolero, PC; Corn, PG; Herman, JG; Liotta, LA; Caporaso, NE; Harris, CC
   Alterations of p14(ARF), p53, and p73 genes involved in the E2F-1-mediatedapoptotic pathways in non-small cell lung carcinoma
   CANCER RESEARCH
   
   S.A. Nicholson et al., "Alterations of p14(ARF), p53, and p73 genes involved in the E2F-1-mediatedapoptotic pathways in non-small cell lung carcinoma", CANCER RES, 61(14), 2001, pp. 5636-5643
4. Jett, JR
   Screening for lung cancer in high-risk groups: Current status of low-dose spiral CT scanning and sputum markers
   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
   
   J.R. Jett, "Screening for lung cancer in high-risk groups: Current status of low-dose spiral CT scanning and sputum markers", SEM RESP CR, 21(5), 2000, pp. 385-392
5. Weitz, JJ; Marschke, RF; Sloan, JA; Grill, JP; Jett, JR; Knost, JA; Hatfield, AK; Zenk, DW; Bate, WW; Schaefer, PL
   A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
   LUNG CANCER
   
   J.J. Weitz et al., "A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer", LUNG CANC, 28(2), 2000, pp. 157-162
6. Bonner, JA; Sloan, JA; Shanahan, TG; Brooks, BJ; Marks, RS; Krook, JE; Gerstner, JB; Maksymiuk, A; Levitt, R; Mailliard, JA; Tazelaar, HD; Hillman, S; Jett, JR
   Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.A. Bonner et al., "Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma", J CL ONCOL, 17(9), 1999, pp. 2681-2691
7. Kirschling, RJ; Grill, JP; Marks, RS; Kugler, JW; Gerstner, JB; Kuross, SA; Michalak, JC; Windschitl, HE; Krewer, KD; Jett, JR
   Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group
   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
   
   R.J. Kirschling et al., "Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group", AM J CL ONC, 22(5), 1999, pp. 517-522
8. Marschke, RF; Grill, JP; Sloan, JA; Wender, DB; Levitt, R; Mailliard, JA; Gerstner, JB; Ghosh, C; Morton, RF; Jett, JR
   Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer
   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
   
   R.F. Marschke et al., "Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer", AM J CL ONC, 22(1), 1999, pp. 15-17
9. Egan, AJM; Boardman, LA; Tazelaar, HD; Swensen, SJ; Jett, JR; Yousem, SA; Myers, JL
   Erdheim-Chester disease - Clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease
   AMERICAN JOURNAL OF SURGICAL PATHOLOGY
   
   A.J.M. Egan et al., "Erdheim-Chester disease - Clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease", AM J SURG P, 23(1), 1999, pp. 17-26
10. Jett, JR
    Is there a role for adjuvant therapy for resected non-small cell lung cancer?
    THORAX
    
    J.R. Jett, "Is there a role for adjuvant therapy for resected non-small cell lung cancer?", THORAX, 54, 1999, pp. S37-S41
11. BENNETT WP; ELDEIRY WS; RUSH WL; GUINEE DG; FREEDMAN AN; CAPORASO NE; WELSH JA; JONES RT; BORKOWSKI A; TRAVIS WD; FLEMING MV; TRASTEK V; PAIROLERO PC; TAZELAAR HD; MIDTHUN D; JETT JR; LIOTTA LA; HARRIS CC
    P21(WAF1 CIP1) AND TRANSFORMING-GROWTH-FACTOR BETA-1 PROTEIN EXPRESSION CORRELATE WITH SURVIVAL IN NONSMALL CELL LUNG-CANCER/
    Clinical cancer research
    
    W.P. Bennett et al., "P21(WAF1 CIP1) AND TRANSFORMING-GROWTH-FACTOR BETA-1 PROTEIN EXPRESSION CORRELATE WITH SURVIVAL IN NONSMALL CELL LUNG-CANCER/", Clinical cancer research, 4(6), 1998, pp. 1499-1506
12. Przygodzki, RM; Bennett, WP; Guinee, DG; Khan, MA; Freedman, A; Shields, PG; Travis, WD; Jett, JR; Tazelaar, H; Pairolero, P; Trastek, V; Liotta, LA; Harris, CC; Caporaso, NE
    p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer
    PHARMACOGENETICS
    
    R.M. Przygodzki et al., "p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer", PHARMACOGEN, 8(6), 1998, pp. 503-511
13. EGAN AJM; BOARDMAN LA; MYERS JL; TAZELAAR HD; ODUFFY JD; SWENSEN SJ; JETT JR
    ERDHEIM-CHESTER-DISEASE CAUSING INTERSTITIAL LUNG-DISEASE
    Modern pathology
    
    A.J.M. Egan et al., "ERDHEIM-CHESTER-DISEASE CAUSING INTERSTITIAL LUNG-DISEASE", Modern pathology, 11(1), 1998, pp. 173-173
14. JUNG SH; LLOYD RV; RUSH WR; PRZYGODZKI R; CAPORASO N; FLEMING MV; BENNETT W; PAIROLERO P; TRASTEK V; JETT JR; LIOTTA LA; HARRIS CC; TAZELAAR HD; TRAVIS WD
    IN-SITU HYBRIDIZATION (ISH) FOR TRANSFORMING-GROWTH-FACTOR (TGF)-BETA-1, (TGF)-BETA-3, AND TGF-RECEPTOR-II (RII) MESSENGER-RNA IN NONSMALL CELL LUNG-CARCINOMA (NSCLC)
    Modern pathology
    
    S.H. Jung et al., "IN-SITU HYBRIDIZATION (ISH) FOR TRANSFORMING-GROWTH-FACTOR (TGF)-BETA-1, (TGF)-BETA-3, AND TGF-RECEPTOR-II (RII) MESSENGER-RNA IN NONSMALL CELL LUNG-CARCINOMA (NSCLC)", Modern pathology, 11(1), 1998, pp. 176-176
15. Maksymiuk, AW; Marschke, RF; Tazelaar, HD; Grill, J; Nair, S; Marks, RS; Brooks, BJ; Mailliard, JA; Burton, GM; Jett, JR
    Phase II trial of topotecan for the treatment of mesothelioma
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    A.W. Maksymiuk et al., "Phase II trial of topotecan for the treatment of mesothelioma", AM J CL ONC, 21(6), 1998, pp. 610-613
16. ARCASOY SM; JETT JR
    PANCOASTS-SYNDROME - REPLY
    The New England journal of medicine
    
    S.M. Arcasoy e J.R. Jett, "PANCOASTS-SYNDROME - REPLY", The New England journal of medicine, 338(11), 1998, pp. 766-766
17. GHAEMMAGHAMI M; JETT JR
    NEW AGENTS IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    Chest
    
    M. Ghaemmaghami e J.R. Jett, "NEW AGENTS IN THE TREATMENT OF SMALL-CELL LUNG-CANCER", Chest, 113(1), 1998, pp. 86-91
18. JETT JR
    UNCOMMON THORACIC TUMORS OF THE LUNG AND MEDIASTINUM - PREFACE
    Seminars in respiratory and critical care medicine
    
    J.R. Jett, "UNCOMMON THORACIC TUMORS OF THE LUNG AND MEDIASTINUM - PREFACE", Seminars in respiratory and critical care medicine, 18(4), 1997, pp. 311-312
19. LUKETICH JD; JETT JR
    THE CURRENT MANAGEMENT OF THYMIC TUMORS
    Seminars in respiratory and critical care medicine
    
    J.D. Luketich e J.R. Jett, "THE CURRENT MANAGEMENT OF THYMIC TUMORS", Seminars in respiratory and critical care medicine, 18(4), 1997, pp. 375-381
20. ARCASOY SM; BAJWA MK; JETT JR
    NON-HODGKINS-LYMPHOMA PRESENTING AS PANCOASTS-SYNDROME
    Respiratory medicine
    
    S.M. Arcasoy et al., "NON-HODGKINS-LYMPHOMA PRESENTING AS PANCOASTS-SYNDROME", Respiratory medicine, 91(9), 1997, pp. 571-573
21. MIDTHUN DE; JETT JR
    CHEMOTHERAPY FOR ADVANCED LUNG-CANCER - WHEN TO EXPECT A RESPONSE
    Postgraduate medicine
    
    D.E. Midthun e J.R. Jett, "CHEMOTHERAPY FOR ADVANCED LUNG-CANCER - WHEN TO EXPECT A RESPONSE", Postgraduate medicine, 101(3), 1997, pp. 187
22. ARCASOY SM; JETT JR
    SUPERIOR PULMONARY SULCUS TUMORS AND PANOASTS-SYNDROME
    The New England journal of medicine
    
    S.M. Arcasoy e J.R. Jett, "SUPERIOR PULMONARY SULCUS TUMORS AND PANOASTS-SYNDROME", The New England journal of medicine, 337(19), 1997, pp. 1370-1376
23. STROLLO DC; ROSADODECHRISTENSON CML; JETT JR
    PRIMARY MEDIASTINAL TUMORS .2. TUMORS OF THE MIDDLE AND POSTERIOR MEDIASTINUM
    Chest
    
    D.C. Strollo et al., "PRIMARY MEDIASTINAL TUMORS .2. TUMORS OF THE MIDDLE AND POSTERIOR MEDIASTINUM", Chest, 112(5), 1997, pp. 1344-1357
24. STROLLO DC; DECHRISTENSON MLR; JETT JR
    PRIMARY MEDIASTINAL TUMORS .1. TUMORS OF THE ANTERIOR MEDIASTINUM
    Chest
    
    D.C. Strollo et al., "PRIMARY MEDIASTINAL TUMORS .1. TUMORS OF THE ANTERIOR MEDIASTINUM", Chest, 112(2), 1997, pp. 511-522
25. JETT JR
    WHATS NEW IN STAGING OF LUNG-CANCER
    Chest
    
    J.R. Jett, "WHATS NEW IN STAGING OF LUNG-CANCER", Chest, 111(6), 1997, pp. 1486-1487
26. TRIVERS GE; DEBENEDETTI VMG; CAWLEY HL; CARON G; HARRINGTON AM; BENNETT WP; JETT JR; COLBY TV; TAZELAAR H; PAIROLERO P; MILLER RD; HARRIS CC
    ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER
    Clinical cancer research
    
    G.E. Trivers et al., "ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER", Clinical cancer research, 2(10), 1996, pp. 1767-1775
27. ROWLAND KM; LOPRINZI CL; SHAW EG; MAKSYMIUK AW; KUROSS SA; JUNG SH; KUGLER JW; TSCHETTER LK; GHOSH C; SCHAEFER PL; OWEN D; WASHBURN JH; WEBB TA; MAILLIARD JA; JETT JR
    RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY
    Journal of clinical oncology
    
    K.M. Rowland et al., "RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY", Journal of clinical oncology, 14(1), 1996, pp. 135-141
28. SHAW EG; FRYTAK S; EAGAN RT; RICHARDSON RL; CREAGAN ET; JETT JR; FOOTE RL; SU JQ; SCHAID DJ; LEE RE
    ETOPOSIDE-CISPLATIN AND THORACIC RADIATION-THERAPY SALVAGE OF INCOMPLETE RESPONDERS TO A NONCISPLATIN INDUCTION REGIMEN FOR LIMITED AND EXTENSIVE SMALL-CELL CARCINOMA OF THE LUNG
    American journal of clinical oncology
    
    E.G. Shaw et al., "ETOPOSIDE-CISPLATIN AND THORACIC RADIATION-THERAPY SALVAGE OF INCOMPLETE RESPONDERS TO A NONCISPLATIN INDUCTION REGIMEN FOR LIMITED AND EXTENSIVE SMALL-CELL CARCINOMA OF THE LUNG", American journal of clinical oncology, 19(2), 1996, pp. 154-158
29. FRYTAK S; SHAW EG; JETT JR; RICHARDSON RL; FOOTE RL; CREAGAN ET; EAGAN RT; SU JQ
    INFUSION CISPLATIN CHEMOTHERAPY AND HYPERFRACTIONATED THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER
    American journal of clinical oncology
    
    S. Frytak et al., "INFUSION CISPLATIN CHEMOTHERAPY AND HYPERFRACTIONATED THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER", American journal of clinical oncology, 19(2), 1996, pp. 193-198
30. BENNETT WP; ELDEIRY WS; GUINEE DG; CAPORASO NE; WELSH JA; JONES RT; BORKOWSKI A; TRAVIS WD; COLBY TV; TRASTEK V; PAIROLERO PC; TAZELAAR HF; MIDTHUN D; JETT JR; LIOTTA LA; VOGELSTEIN B; HARRIS CC
    P53 P21((WAF1/CIP1)) EXPRESSION IN HUMAN LUNG-CANCER/
    Laboratory investigation
    
    W.P. Bennett et al., "P53 P21((WAF1/CIP1)) EXPRESSION IN HUMAN LUNG-CANCER/", Laboratory investigation, 74(1), 1996, pp. 895-895
31. CASTRO M; VEEDER MH; MAILLIARD JA; TAZELAAR HD; JETT JR
    A PROSPECTIVE-STUDY OF PULMONARY-FUNCTION IN PATIENTS RECEIVING MITOMYCIN
    Chest
    
    M. Castro et al., "A PROSPECTIVE-STUDY OF PULMONARY-FUNCTION IN PATIENTS RECEIVING MITOMYCIN", Chest, 109(4), 1996, pp. 939-944
32. HRUSZKEWYCZ AM; DELGADO RM; PRZYGODZKI RM; TRAVIS WD; JETT JR; COLBY TV; LIOTTA LA; KHAN MA; HARRIS CC; BENNETT WP
    RAPID BASE SEQUENCE-ANALYSIS OF MUTANT HUMAN K-RAS ONCOGENE USING SEMIAUTOMATED COLD SSCP
    Clinical chemistry
    
    A.M. Hruszkewycz et al., "RAPID BASE SEQUENCE-ANALYSIS OF MUTANT HUMAN K-RAS ONCOGENE USING SEMIAUTOMATED COLD SSCP", Clinical chemistry, 42(6), 1996, pp. 435-435
33. ALBERTI W; ANDERSON G; BARTOLUCCI A; BELL D; VILLALBA JB; BRODIN O; CARDIELLO C; CARTEI F; CARTEI G; CELLERINO R; CHASTANG C; CORMIER Y; COX JD; CRINO L; CROWLEY J; DAUTZENBERG B; DEPIERRE A; DIETEMANN A; DILLMAN RO; DOI O; FELD R; FIGLIN R; GANZ PA; GREEN MR; GREGOR A; HELLE PA; HERNDON JE; HITOMI S; HOST H; IMAIZUMI M; JETT JR; JOHNSON D; KAASA S; KIMURA H; KLASTERSKY J; KONDO H; KREISMAN H; KRIS MG; KUNISHIMA K; KUWAHARA O; LAD TE; LAING AH; MACBETH F; MASAOKA A; MATTSON K; MINATEL E; MIRA JG; MORI T; MOUNTAIN CF; NIEDERLE N; NIIRANEN A; NOU E; PAGE W; PATER J; PIANTADOSI S; PISTERS KMW; PYRHONEN S; QUOIX E; RAPP E; ROWELL NP; SAHMOUD T; SAWAMURA K; SCHALLIER DCC; SCOTT C; SIMPSON J; STAGG M; TERAMATSU T; TROVO MG; TSUCHIYA R; TUMMARELLO D; VANHOUTTE P; VANZANDWIJK N; VINCENT RG; WADA H; WHITE JE; WILLIAMS CJ; WOODS RL; YAMAGUCHI Y; ARRIAGADA R; CARTMELLDAVIES J; GIRLING DJ; LECHEVALIER T; MARSONI S; PARMAR MKB; PIGNON JP; REKACEWICZ C; SOUHAMI RL; STEWART LA; TARAYRE M; TINAZZI A; TONI V
    CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
    BMJ. British medical journal
    
    W. Alberti et al., "CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS", BMJ. British medical journal, 311(7010), 1995, pp. 899-909
34. JETT JR; KIRSCHLING RJ; JUNG SH; MARKS RS
    A PHASE-II STUDY OF PACLITAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A STUDY OF THE NORTH CENTRAL CANCER-TREATMENT GROUP
    Seminars in oncology
    
    J.R. Jett et al., "A PHASE-II STUDY OF PACLITAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A STUDY OF THE NORTH CENTRAL CANCER-TREATMENT GROUP", Seminars in oncology, 22(3), 1995, pp. 75-77
35. JETT JR
    MALIGNANT PLEURAL MESOTHELIOMA - A PROPOSED NEW STAGING SYSTEM
    Chest
    
    J.R. Jett, "MALIGNANT PLEURAL MESOTHELIOMA - A PROPOSED NEW STAGING SYSTEM", Chest, 108(4), 1995, pp. 895-897
36. LOPRINZI CL; GOLDBERG RM; SU JQ; MAILLIARD JA; KUROSS SA; MAKSYMIUK AW; KUGLER JW; JETT JR; GHOSH C; PFEIFLE DM; WENDER DB; BURCH PA
    PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    C.L. Loprinzi et al., "PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 12(6), 1994, pp. 1126-1129
37. LIENGSWANGWONG V; BONNER JA; SHAW EG; FOOTE RL; FRYTAK S; EAGAN RT; JETT JR; RICHARDSON RL; CREAGAN ET; SU JQ
    LIMITED-STAGE SMALL-CELL LUNG-CANCER - PATTERNS OF INTRATHORACIC RECURRENCE AND THE IMPLICATIONS FOR THORACIC RADIOTHERAPY
    Journal of clinical oncology
    
    V. Liengswangwong et al., "LIMITED-STAGE SMALL-CELL LUNG-CANCER - PATTERNS OF INTRATHORACIC RECURRENCE AND THE IMPLICATIONS FOR THORACIC RADIOTHERAPY", Journal of clinical oncology, 12(3), 1994, pp. 496-502
38. JETT JR; SU JQ; KROOK JE; GOLDBERG RM; KUGLER JW
    MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER
    Journal of clinical oncology
    
    J.R. Jett et al., "MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER", Journal of clinical oncology, 12(12), 1994, pp. 2677-2681
39. JETT JR; MAKSYMIUK AW; SU JQ; MAILLIARD JA; KROOK JE; TSCHETTER LK; KARDINAL CG; TWITO DI; LEVITT R; GERSTNER JB
    PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    J.R. Jett et al., "PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 12(11), 1994, pp. 2321-2326
40. SHAW EG; SU JQ; EAGAN RT; JETT JR; MAKSYMIUK AW; DEIGERT FA
    PROPHYLACTIC CRANIAL IRRADIATION IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER - ANALYSIS OF THE MAYO-CLINIC AND NORTH-CENTRAL-CANCER-TREATMENT-GROUP DATA-BASES
    Journal of clinical oncology
    
    E.G. Shaw et al., "PROPHYLACTIC CRANIAL IRRADIATION IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER - ANALYSIS OF THE MAYO-CLINIC AND NORTH-CENTRAL-CANCER-TREATMENT-GROUP DATA-BASES", Journal of clinical oncology, 12(11), 1994, pp. 2327-2332
41. MAKSYMIUK AW; JETT JR; EARLE JD; SU JQ; DIEGERT FA; MAILLIARD JA; KARDINAL CG; KROOK JE; VEEDER MH; WIESENFELD M; TSCHETTER LK; LEVITT R
    SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL
    Journal of clinical oncology
    
    A.W. Maksymiuk et al., "SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL", Journal of clinical oncology, 12(1), 1994, pp. 70-76
42. WIESENFELD A; JETT JR; SU JQ; BRAICH TA; KARDINAL CG; MAILLIARD JA; VEEDER MH; MORTON RF; MICHALAK JC
    PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER
    Cancer
    
    A. Wiesenfeld et al., "PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER", Cancer, 73(4), 1994, pp. 1189-1193
43. JETT JR
    CURRENT TREATMENT OF UNRESECTABLE LUNG-CANCER
    Mayo Clinic proceedings
    
    J.R. Jett, "CURRENT TREATMENT OF UNRESECTABLE LUNG-CANCER", Mayo Clinic proceedings, 68(6), 1993, pp. 603-611
44. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
    A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP
    Cancer
    
    D.H. Gesme et al., "A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP", Cancer, 71(9), 1993, pp. 2723-2726
45. PUJOL JL; GIBNEY DJ; SU JQ; MAKSYMIUK AW; JETT JR
    IMMUNE-RESPONSE INDUCED IN SMALL-CELL LUNG-CANCER BY MAINTENANCE THERAPY WITH INTERFERON-GAMMA
    Journal of the National Cancer Institute
    
    J.L. Pujol et al., "IMMUNE-RESPONSE INDUCED IN SMALL-CELL LUNG-CANCER BY MAINTENANCE THERAPY WITH INTERFERON-GAMMA", Journal of the National Cancer Institute, 85(22), 1993, pp. 1844-1850